Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trialCharu Aggarwal, Nehal J. Lakhani, Anthony W. Tolcher et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 140
Dual Targeting of the Epidermal Growth Factor Receptor Using the Combination of Cetuximab and Erlotinib: Preclinical Evaluation and Results of the Phase II DUX Study in Chemotherapy-Refractory, Advanced Colorectal CancerAndrew Weickhardt, Niall C. Tebbutt|Journal of Clinical Oncology|2012Cited by 109
Comparison of radiologically inserted arm ports <i>versus</i> surgically placed chest ports for chemotherapyAndrew Weickhardt, Geoff Chong, Timothy Joseph et al.|Asia-Pacific Journal of Clinical Oncology|2009Cited by 10